Synthetic biologists.
Data scientists.

Together, we’re making designer mRNA drugs to cure serious illnesses.

Drugs that leverage our immune system rather than work against it. Drugs that are more accessible to more people. Drugs that put humans first.


Yusuf Erkul

Yusuf Erkul MD, MBA

Chief Executive Officer & Cofounder

Physician entrepreneur who developed an FDA-approved cancer drug at Merck & Co
Burak Yilmaz

Burak Yilmaz MS

President & Cofounder

Serial entrepreneur and synthetic biologist who founded his first biotech company at age 22
Manfred Kraus

Manfred Kraus PhD

VP, Head of R&D Therapeutics

Firat Ileri

Firat Ileri

Board Member

Pablo Lubroth

Pablo Lubroth MPhil

Board Observer

Gladys Nunez

Gladys Nunez

Board Observer

Matthew Strout

Matthew Strout MD, PhD

VP of Business Development

Stephen DiPalma

Stephen DiPalma MBA

Chief Financial Officer

Balkrishen Bhat

Balkrishen Bhat PhD

Head of LNP Formulation

Cafer Ozdemir

Cafer Ozdemir PhD

Director of Convergence Science & Cofounder

Ryan Landis

Ryan Landis PhD

Principal Scientist / LNP Formulation

Yulia Rybakova

Yulia Rybakova PhD

Senior Research Scientist

Kelly Brock

Kelly Brock

Senior Computational Biologist

Jieni Xu

Jieni Xu PhD, PMP

Senior Scientist, LNP Formulation

Rudy Christmas

Rudy Christmas

Scientist II , Immuno Oncology

Pedro Rivera Pomales

Pedro Rivera Pomales

Process Development Scientist

Isaak Mueller

Isaak Mueller PhD

Scientist, Synthetic Biology

Maxwell Alexander

Maxwell Alexander MS

Data Scientist, Computational Biology

Sadik Yildiz

Sadik Yildiz PhD

Data Scientist, Computational Biology

Tom Addison

Tom Addison

Senior Associate Scientist, Synthetic Biology

Leona Lee

Leona Lee MS

Research Associate II, Synthetic Biology

Mark Krimmer

Mark Krimmer

Research Associate, LNP Formulation


Arthur Krieg

Arthur Krieg MD

Clinical Advisor, Nucleic Acid Therapeutics

Founder / CEO / CSO of 4 successful nucleic acid companies
Edward Benz Jr

Edward Benz Jr MD

Clinical Advisor, Medical Oncology

President & CEO Emeritus of Dana Farber Cancer Institute, Harvard Medical School
Peter <br>Blume-Jensen


Clinical Advisor, Cancer Drug Development

CEO of Acrivon Therapeutics and former Head of Oncology at of Merck
Nikolai Slavov

Nikolai Slavov PhD

Scientfic Advisor, mRNA Translation

Associate Professor, Northeastern University
Dean <br>Felsher


Clinical Advisor, Translational Oncology

Director of Stanford Medicine Translational Research & Applied Medicine at Stanford Medical School
Dan Peer

Dan Peer PhD

Scientific Advisor

Vice President for R&D, Tel Aviv University